Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lexaria Bioscience Corp. stock logo
LEXX
Lexaria Bioscience
$0.61
+1.4%
$0.81
$0.46
$1.55
$14.93M0.37210,627 shs120,780 shs
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
$2.70
-0.4%
$2.71
$2.33
$4.96
$16.74M0.418,533 shs12,603 shs
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
$0.64
-9.9%
$0.86
$0.50
$6.19
$3.97M0.382.35 million shs799,348 shs
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
$3.69
+36.7%
$5.20
$1.11
$19.65
$14.77M0.043,922 shs6,966 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lexaria Bioscience Corp. stock logo
LEXX
Lexaria Bioscience
+1.41%-4.65%-40.11%-1.86%-42.37%
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
-0.37%-1.46%-1.82%-22.64%-16.41%
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
-9.86%-9.34%-26.78%-42.34%-89.03%
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
+36.67%-7.75%+74.12%-63.10%-79.50%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lexaria Bioscience Corp. stock logo
LEXX
Lexaria Bioscience
$0.61
+1.4%
$0.81
$0.46
$1.55
$14.93M0.37210,627 shs120,780 shs
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
$2.70
-0.4%
$2.71
$2.33
$4.96
$16.74M0.418,533 shs12,603 shs
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
$0.64
-9.9%
$0.86
$0.50
$6.19
$3.97M0.382.35 million shs799,348 shs
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
$3.69
+36.7%
$5.20
$1.11
$19.65
$14.77M0.043,922 shs6,966 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lexaria Bioscience Corp. stock logo
LEXX
Lexaria Bioscience
+1.41%-4.65%-40.11%-1.86%-42.37%
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
-0.37%-1.46%-1.82%-22.64%-16.41%
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
-9.86%-9.34%-26.78%-42.34%-89.03%
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
+36.67%-7.75%+74.12%-63.10%-79.50%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Lexaria Bioscience Corp. stock logo
LEXX
Lexaria Bioscience
2.00
Hold$1.50145.54% Upside
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
1.00
SellN/AN/A
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
1.00
SellN/AN/A
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest SHPH, NAII, LEXX, and ZIVO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/4/2026
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
UpgradeSell (E)Sell (E+)
4/22/2026
Lexaria Bioscience Corp. stock logo
LEXX
Lexaria Bioscience
UpgradeSell (E+)Sell (D-)
(Data available from 5/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Lexaria Bioscience Corp. stock logo
LEXX
Lexaria Bioscience
$368K41.15N/AN/A$0.13 per share4.70
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
$129.86M0.13N/AN/A$11.07 per share0.24
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
N/AN/AN/AN/A$1.11 per shareN/A
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
$15.85K931.70N/AN/A($0.81) per share-4.56
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Lexaria Bioscience Corp. stock logo
LEXX
Lexaria Bioscience
-$11.90M-$0.47N/AN/AN/A-1,685.84%-206.02%-162.53%7/13/2026 (Estimated)
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
-$13.57M-$2.04N/AN/AN/A-9.06%-8.60%-3.92%N/A
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
-$11.72M-$11.84N/AN/AN/AN/A-444.90%-188.81%N/A
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
-$7.78M-$2.59N/AN/AN/AN/AN/A-2,240.92%N/A

Latest SHPH, NAII, LEXX, and ZIVO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/13/2026Q2 2026
Lexaria Bioscience Corp. stock logo
LEXX
Lexaria Bioscience
-$0.0950-$0.06+$0.0350-$0.06$0.05 million$0.02 million
3/31/2026Q4 2025
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
N/A$0.06N/A$0.06N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Lexaria Bioscience Corp. stock logo
LEXX
Lexaria Bioscience
N/AN/AN/AN/AN/A
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
N/AN/AN/AN/AN/A
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
N/AN/AN/AN/AN/A
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Lexaria Bioscience Corp. stock logo
LEXX
Lexaria Bioscience
N/A
26.84
26.84
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
0.13
1.87
0.85
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
N/A
0.06
0.06
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
N/A
0.17
0.17
CompanyEmployeesShares OutstandingFree FloatOptionable
Lexaria Bioscience Corp. stock logo
LEXX
Lexaria Bioscience
724.79 million22.71 millionNot Optionable
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
2906.18 million4.89 millionNot Optionable
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
55.59 million4.89 millionNot Optionable
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
104.00 million2.91 millionNot Optionable

Recent News About These Companies

Zivo Bioscience Inc. Wt
ZIVO Bioscience Provides Special Letter to Shareholders
ZIVO Bioscience releases letter to shareholders
Harmony Biosciences Holdings
Regencell Bioscience Holdings Ltd RGC
ZIVO Bioscience Announces Uplisting to OTCQB Market
Ideaya Biosciences
Dare Bioscience Inc DARE
Zivo Bioscience Inc (ZIVO) USD0.001

New MarketBeat Followers Over Time

Media Sentiment Over Time

Lexaria Bioscience stock logo

Lexaria Bioscience NASDAQ:LEXX

$0.61 +0.01 (+1.41%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$0.62 +0.00 (+0.67%)
As of 07:34 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods. The company's DehydraTECH is used with a range of active molecules encompassing fat-soluble vitamins, pain medications, hormones, PDE5 inhibitors, antivirals, oral nicotine and its analogs, and cannabinoids. Its DehydraTECH technology evaluates therapeutic indications, including hypertension, heart disease, and diabetes; and is suitable for a variety of product formats, such as pharmaceuticals, nutraceuticals, over the counter, and consumer packaged goods. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.

Natural Alternatives International stock logo

Natural Alternatives International NASDAQ:NAII

$2.70 -0.01 (-0.33%)
As of 05/14/2026 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. The company was founded in 1980 and is headquartered in Carlsbad, California.

Shuttle Pharmaceuticals stock logo

Shuttle Pharmaceuticals NASDAQ:SHPH

$0.64 -0.07 (-9.86%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$0.67 +0.03 (+4.69%)
As of 08:16 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers . The company is based in Gaithersburg, Maryland.

ZIVO Bioscience stock logo

ZIVO Bioscience NASDAQ:ZIVO

$3.69 +0.99 (+36.67%)
As of 05/14/2026 03:25 PM Eastern

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.